Stock Trading Ideas

Decoding The FFIE Surge: Inside Faraday Future's Nasdaq Rally
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Confluent Set to Capture Major Market Share with Unique Streaming Tech: Oppenheimer Analyst
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Confluent Set to Capture Major Market Share with Unique Streaming Tech: Oppenheimer Analyst
Robinhood Sees Surge in Trading as Bull Market Returns, Analyst Upgrades Stock
Walmart Growth Incentives 'Are Hitting Stride', 6 Analysts Explore Q1 Earnings

Trading Ideas Recent News

After Start of SEC's 'War on DeFi' UNI and Others Struggle to Recover
It has now been over a month since it was revealed that Uniswap Labs (CRYPTO: UNI) had received a Wells Notice, indicating the U.S. Securities and Exchange Commission intends to bring charges against the developers of the largest decentralized exchange.
Macro Continues to be a Key Driver for Crypto: Coinbase
The macro environment continues to be a key driver for crypto performance, according to a Coinbase (NASDAQ: COIN) report.
Curtiss-Wright Rewards Investors With Buyback, Ups Dividend
Curtiss-Wright Corporation (NYSE: CW) announced that its board of directors approved a hike in its quarterly dividend to 21 cents per share, reflecting an increase of 5% from the prior payout. With the current hike, Curtiss-Wright will now pay out an annual dividend of 84 cents per share.
Microchip Boosts Aerospace Portfolio With New Launch
Microchip Technology (NASDAQ: MCHP) is expanding its footprint in the aerospace and defense industry by introducing the SAMD21RT, a radiation-tolerant 32-bit microcontroller (MCU) based on the Arm Cortex-M0+ architecture.
3 Large-Cap Growth Funds to Buy as Inflation Cools in April
Inflation has been a major concern lately as uncertainty has been growing over the Federal Reserve's timing of rate cuts. However, much to consumers' relief, inflation finally eased in April after moving north in the first months of the year.
Ionis, Biogen Down on Ending Development of ALS Drug
Shares of Ionis Pharmaceuticals (NASDAQ: IONS) and Biogen (NASDAQ: BIIB) lost at least 2% in market cap on Thursday after the companies announced their decision to terminate the development of their investigational amyo
3 Tobacco Stocks Worth Watching Amid Industry Challenges
The Zacks Tobacco industry players have been witnessing soft cigarette sales volumes due to inflation, changing consumer habits, and stringent regulations. Increased costs of essential materials further raise concerns for profit margins.
Implied Volatility Surging for TriplePoint Venture Stock Options
Investors in TriplePoint Venture Growth BDC Corp (NYSE: TPVG) need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 21, 2024 $5 Call had some of the highest implied volatility of all equity options today.
Haemonetics Stock Up 10.9% YTD: Will the Rally Continue?
Haemonetics Corporation‘s (NYSE: HAE) shares have increased 10.8% year to date compared with the industry's rise of 6.1%. The Medical sector has gained 1% in the said time frame. The company has a market capitalization of $4.82 billion.
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021.
Cash From Tier 1 Asset Flows to Silver Producer
Source: Streetwise Reports 05/15/2024
HealthEquity Closes Conduent's BenefitWallet Acquisition
HealthEquity (NASDAQ: HQY) recently announced the completion of the acquisition of Conduent's BenefitWallet Health Savings Account portfolio. In September 2023, HealthEquity entered into an agreement to acquire the BenefitWallet HSA portfolio from Conduent Business Services, LLC
Should Investors Buy the Dip in Deere & Company's Stock After Earnings?
Despite exceeding top and bottom line expectations for its fiscal second quarter this morning, Deere & Company's (NYSE: DE) stock dropped -5% in Thursday's trading session after lowering its fiscal 2024 net income guidance.
Cool Company Ltd. Surges 5.6%: Is This an Indication of Further Gains?
Cool Company Ltd. (NYSE: CLCO) shares ended the last trading session 5.6% higher at $12.39. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 9.6% gain over the past four weeks.
Telegram CEO Pavel Durov Appears to Endorse Notcoin Following Launch on TON Blockchain
Telegram CEO Pavel Durov appeared to endorse the web3 game Notcoin on Friday, which launched its NOT token on The Open Network (CRYPTO: TON) blockchain yesterday.
EXCLUSIVE: GameStop, AMC Buzz 'May Prove To Be Short-Lived,' CEO Of Company Behind MEME ETF Tells Benzinga
The company behind the MEME ETF shares what it would take to bring the meme stock fund back to the market.
Crude Oil Gains 1%; GameStop Shares Plunge
Netflix's Advertising Strategy Promises Big, with 40M Ad-Supported Viewers and Unique Ad Integration Plans, Analysts Says After Event
Oppenheimer analyst reiterated Outperform rating on Netflix with price target of $725. Netflix showcased robust content slate, ad partnerships, & upcoming ad platform launch. Ad revenue ramp may take time. Other analysts maintained Neutral/Sell ratings.
Analysts Remain Bullish on Take-Two Interactive Despite GTA VI Delay, Anticipate Strong Long-Term Growth
Take-Two Interactive Software posted strong FY4Q results, with a FY2025 net bookings outlook of $5.55-$5.65 billion. Stifel's Drew Crum noted the anticipation around GTA VI's fall 2025 launch, despite some frustration from investors. Analysts from Stifel, Benchmark, and Roth MKM reiterated their Buy ratings, with price targets ranging from $175 to $200, citing optimism for long-term growth.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers